[
  {
    "ts": null,
    "headline": "AbbVie: Q2 Earnings Warning Reflects Poor R&D, But It's Not A Red Flag",
    "summary": "AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips. Click to read why ABBV is a Hold.",
    "url": "https://finnhub.io/api/news?id=5e4015f4eb7e32dab0d055fc53b5bc43b7e8e8927cd824d8ce12d17f699dca9f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751641200,
      "headline": "AbbVie: Q2 Earnings Warning Reflects Poor R&D, But It's Not A Red Flag",
      "id": 135754377,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2202089733/image_2202089733.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips. Click to read why ABBV is a Hold.",
      "url": "https://finnhub.io/api/news?id=5e4015f4eb7e32dab0d055fc53b5bc43b7e8e8927cd824d8ce12d17f699dca9f"
    }
  }
]